alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(1)
    
    The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
  /s/ Paula J. MeilerPaula J. Meiler Senior Vice Presidentand Chief Financial Officer 
 *
    
    This certification is being furnished as required by Rule 13a-14(b) under the Securities Exchange
Act of 1934 (the Exchange Act) and Section 1350 of Chapter 63 of Title 18 of the United States
Code, and shall not be deemed filed for purposes of Section 18 of the Exchange Act or otherwise
subject to the liability of that section. This certification shall not be deemed to be incorporated
by reference into any filing under the Securities Act of 1933 or the Exchange Act, except as
otherwise stated in such filing. 29.
# C_2016202EN.01002201.xml

| 7.6.2016 | EN | Official Journal of the European Union | C 202/22 |
| --- | --- | --- | --- |

7.6.2016

EN

Official Journal of the European Union

C 202/22

---

Article 13

1.   The Union shall have an institutional framework which shall aim to promote its values, advance its objectives, serve its interests, those of its citizens and those of the Member States, and ensure the consistency, effectiveness and continuity of its policies and actions.

The Union's institutions shall be:

| — | the European Parliament, |
| --- | --- |

—

the European Parliament,

| — | the European Council, |
| --- | --- |

—

the European Council,

| — | the Council, |
| --- | --- |

—

the Council,

| — | the European Commission (hereinafter referred to as ‘the Commission’), |
| --- | --- |

—

the European Commission (hereinafter referred to as ‘the Commission’),

| — | the Court of Justice of the European Union, |
| --- | --- |

—

the Court of Justice of the European Union,

| — | the European Central Bank, |
| --- | --- |

—

the European Central Bank,

| — | the Court of Auditors. |
| --- | --- |

—

the Court of Auditors.

2.   Each institution shall act within the limits of the powers conferred on it in the Treaties, and in conformity with the procedures, conditions and objectives set out in them. The institutions shall practice mutual sincere cooperation.

3.   The provisions relating to the European Central Bank and the Court of Auditors and detailed provisions on the other institutions are set out in the Treaty on the Functioning of the European Union.

4.   The European Parliament, the Council and the Commission shall be assisted by an Economic and Social Committee and a Committee of the Regions acting in an advisory capacity.

---
##### 



nd
   Compensation
   Quarterly Performance:
 Annual Performance At Plan:
 Increasing Annual Profitability:
  Stock Options
  Benefits




---



##### 



Relocation
  
    
    Professional relocation assistance by our corporate provider, Relocation Today. You
can utilize a realtor that they recommend or work with one outside of their referral
group.
    
    Commuting expenses for a period of eight (8) months. This includes one roundtrip
airfare per week for either you or your wife.
    
    The company will secure temporary housing for a period of eight (8) months. If you
elect an alternative termporary housing arrangement, we will reimburse your expenses
for a period of four (4) months.
    
    Automobile expenses for the first 30 days in Minnesota.
    
    Shipment and temporary storage of household goods.
    
    Realtor fees and closing costs on the sale of your existing home.
    
    Closing costs on the purchase of your new home. This will not include points paid
on the purchase of a new home, real estate taxes or any other extraordinary closing
costs.
    
    Reimbursement of any other reasonable expenses not listed above as approved by myself.
    
    A gross-up of all taxable relocation expenses.
  Other




---



##### 



Digi International Employment Agreement
   February 5, 2003
   Digi International Inc.
 
  Offer accepted:
 /s/ Lawrence A. Kraft
    
    2/5/03
    
    2/10/03Lawrence A. Kraft
    
    Date
    
    Start Date
SHIPPING DIAGNOSTIC SAMPLES

7-10

6 SHIPPING TO NVSL FADDL

FEDEX® PRIORITY WEEKDAY OVERNIGHT

A. RECIPIENT INFO

Name: FAD Priority 1,2,3,A 

Phone: (631) 323-3256

Company: USDA/APHIS/FADDL

Address: Orient Point Warehouse, 40550 Rte 25 

City: Orient Point State: NY Zip: 11957

B. HOLD LOCATION (REQUIRED)

Hold Location Address: 

579 Edwards Ave., Calverton, NY 11933

This address must be included; It enables NVSL 

FADDL personnel to pick up the package as soon 

as possible in the morning, therefore allowing a 

full day of laboratory testing and studies.

C. BILLING 

Bill to Sender, using the billing number or 

account number obtained from the AVIC.

D. BILLING REFERENCE

For Internal Billing Reference, use the 

accounting code obtained from the AVIC. 

E. HOLDING

Samples received Monday–Friday: 

Check HOLD Weekday.

F. SERVICE

Check FedEx® Priority Overnight.

G. SPECIAL HANDLING

Check Direct Signage.

Check Yes, Shipper’s Declaration not required.

Remember to retain the Sender’s Copy of the 

airbill for your records.

631 323-3256

USDA/APHIS/FADDL

FAD Priority 1,2,3,A

1 10

Orient Point Warehouse, 40550 Rte 25

Orient Point NY 11957

579 Edwards Ave, Calverton, NY 11933

a

b

e

c

d

f

g

All samples to be shipped to NVSL FADDL must be shipped via FedEx® Priority Overnight. 

Phone contact or notification must be made with NVSL FADDL prior to shipment. IMPORTANT

X

X

X

X

X

X

(For samples to be received Monday–Friday)
# C_2018142EN.01006602.xml

| 23.4.2018 | EN | Official Journal of the European Union | C 142/66 |
| --- | --- | --- | --- |

23.4.2018

EN

Official Journal of the European Union

C 142/66

---

Action brought on 22 February 2018 — IQ Group Holdings Berhad v EUIPO — Krinner Innovation (Lumiqs)

(Case T-133/18)

(2018/C 142/85)

Language in which the application was lodged: English

Parties

Parties

Applicant: IQ Group Holdings Berhad (Heckmondwike, United Kingdom) (represented by: S. Carter, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Other party to the proceedings before the Board of Appeal: Krinner Innovation GmbH (Straßkirchen, Germany)

Other party to the proceedings before the Board of Appeal:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Applicant

Applicant of the trade mark at issue:

Trade mark at issue: International registration designating the European Union in respect of figurative mark Lumiqs — International registration designating the European Union No 1 220 053

Trade mark at issue:

Procedure before EUIPO: Opposition proceedings

Procedure before EUIPO

Contested decision: Decision of the First Board of Appeal of EUIPO of 12 December 2017 in Case R 983/2017-1.

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | allow the application to proceed to registration in respect of the contested goods as amended; |
| --- | --- |

—

allow the application to proceed to registration in respect of the contested goods as amended;

| — | order EUIPO to pay the costs incurred by the applicant in connection with this appeal. |
| --- | --- |

—

order EUIPO to pay the costs incurred by the applicant in connection with this appeal.

Plea in law

Plea in law

| — | Infringement of Article 8(1)(b) of Regulation No 2017/1001. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation No 2017/1001.

---
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                         1,886,297
<SECURITIES>                                   0
<RECEIVABLES>                                  190,270
<ALLOWANCES>                                   0
<INVENTORY>                                    1,990,174
<CURRENT-ASSETS>                               4,112,384
<PP&E>                                         884,707
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 5,082,944
<CURRENT-LIABILITIES>                          164,742
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       17,434
<OTHER-SE>                                     4,784,897
<TOTAL-LIABILITY-AND-EQUITY>                   5,082,944
<SALES>                                        7,319,259
<TOTAL-REVENUES>                               7,319,259
<CGS>                                          2,234,297
<TOTAL-COSTS>                                  3,964,415
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             9,445
<INCOME-PRETAX>                                1,111,102
<INCOME-TAX>                                   441,600
<INCOME-CONTINUING>                            669,502
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   669,502
<EPS-PRIMARY>                                  0.04
<EPS-DILUTED>                                  0.00
        


</TABLE>
January 15, 2003

VETERINARY SERVICES MEMORANDUM NO. 800.108

SUBJECT: Inventory and Disposition Records

TO: Veterinary Biologics Licensees, Permittees, Distributors, and Applicants

Directors, Center for Veterinary Biologics

Regional Directors, Veterinary Services

Area Veterinarians in Charge, Veterinary Services

State Veterinarians

Investigative and Enforcement Services

I. PURPOSE

This memorandum clarifies the recordkeeping responsibilities of licensees, permittees, and distributors 

concerning the sale, shipment, or other disposition of biological products subject to the Virus-SerumToxin Act. 

II. BACKGROUND

Title 9, Code of Federal Regulations (9 CFR), Section 116.2, requires each licensee, permittee, and 

distributor of biological products to maintain detailed disposition records showing the sale, shipment, 

or other disposition made of the biological products handled by such person. Such records are subject 

to inspection by APHIS pursuant to 9 CFR, Section 115.2.

Section 115.2 of the regulations provides that any biological product, the container of which bears a 

United States veterinary license number or a United States veterinary permit number may be inspected 

at any time or place to ensure that such product is not worthless, contaminated, dangerous, or harmful. 

If worthless, contaminated, dangerous, or harmful product is found as a result of such inspection, it 

could be subject to seizure, detention, or condemnation procedures in accordance with the regulations 

under 9 CFR 118.

Inspection of product and review of inventory and disposition records may be necessary in order to 

account for each product and to enable specific products to be traced.

III. PROCEDURES

Each licensee, permittee, and distributor of biologicals sold in the U.S. must maintain for APHIS 

review detailed inventory and disposition records showing the sale, shipment, or other disposition 

made of the biological products handled by such person.

 /s/ W. Ron DeHaven

W. Ron DeHaven

Deputy Administrator

Veterinary Services
# C_2023216EN.01003801.xml

| 19.6.2023 | EN | Official Journal of the European Union | C 216/38 |
| --- | --- | --- | --- |

19.6.2023

EN

Official Journal of the European Union

C 216/38

---

Judgment of the General Court of 26 April 2023 — CV v Commission

(Case T-20/18) (1)

(Civil service - Officials - Social security - Article 73 of the Staff Regulations - Common rules on the insurance against the risk of accident and of occupational disease - Occupational disease - Medical Committee - Article 22 - Refusal to recognise the occupational nature of a disease - Proper conduct of the pre-litigation procedure - Obligation to state reasons)

(2023/C 216/48)

Language of the case: French

Parties

Applicant: CV (represented by: F. Moyse and L. Heisten, lawyers)

Defendant: European Commission (represented by: T.S. Bohr and L. Vernier, acting as Agents)

Re:

By his action under Article 270 TFEU, the applicant seeks, first, the annulment of the decision of the European Commission of 20 March 2017 rejecting his application for recognition of the occupational origin of his disease and the decision of the Commission of 15 March 2017 imposing on the applicant certain costs and fees of the members of the Medical Committee that ruled on that application and, secondly, compensation for the material and non-material damage which the applicant claims to have suffered as a result of those decisions.

Operative part of the judgment

The Court:

| 1. | Dismisses the action; |
| --- | --- |

1.

Dismisses the action;

| 2. | Orders CV to pay the costs. |
| --- | --- |

2.

Orders CV to pay the costs.

---

(1)  OJ C 112, 26.3.2018.

---
17427

#### Henry v. State Farm

April 17, 1997

Order No. 97-40

Affirmed
# C_2019072EN.01003401.xml

| 25.2.2019 | EN | Official Journal of the European Union | C 72/34 |
| --- | --- | --- | --- |

25.2.2019

EN

Official Journal of the European Union

C 72/34

---

Action brought on 17 December 2018 — Darment v Commission

(Case T-739/18)

(2019/C 72/43)

Language of the case: English

Parties

Applicant: Darment Oy (Helsinki, Finland) (represented by: C. Ginter, lawyer)

Defendant: European Commission

Form of order sought

The applicant claims that the Court should:

| — | annul the Commission decision to reduce the quota allocated to the applicant for the year 2019 for the placing of hydrofluorocarbons on the market about which the applicant was informed by the letter of 16 October 2018 Ares(2018)5305174 and email of 12 December 2018; |
| --- | --- |

—

annul the Commission decision to reduce the quota allocated to the applicant for the year 2019 for the placing of hydrofluorocarbons on the market about which the applicant was informed by the letter of 16 October 2018 Ares(2018)5305174 and email of 12 December 2018;

| — | order the defendant to pay the costs. |
| --- | --- |

—

order the defendant to pay the costs.

Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.

| 1. | First plea in law, alleging infringement of Regulation (EU) 517/2014 (1) from the defendant, by applying Article 25(2) strictly based on the data available in the registry set up under Article 17, even though a claim has been raised to correct the erroneous data in the registry. |
| --- | --- |

1.

First plea in law, alleging infringement of Regulation (EU) 517/2014 (1) from the defendant, by applying Article 25(2) strictly based on the data available in the registry set up under Article 17, even though a claim has been raised to correct the erroneous data in the registry.

| 2. | Second plea in law, alleging a manifest error of assessment from the defendant for refusing to consider the applicant’s explanations regarding placement of quota for bulk import on the market. |
| --- | --- |

2.

Second plea in law, alleging a manifest error of assessment from the defendant for refusing to consider the applicant’s explanations regarding placement of quota for bulk import on the market.

---

(1)  Regulation (EU) No 517/2014 of the European Parliament and of the Council of 16 April 2014 on fluorinated greenhouse gases and repealing Regulation (EC) No 842/2006, OJ L 150, 20.05.2014, p. 150.

---
|   | 1. | I have reviewed this annual report on Form 10-K/A of Lapis Technologies, Inc.; and |
|--------|----|------------------------------------------------------------------------------------|

|   | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ David Lucatz                                                 |
|------------------------------------------------------------------|
| David LucatzChief Executive Officer(Principal Executive Officer) |

----
##### 



EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Great Western Land and Recreation, Inc. (the Company) for
the year ended September 30, 2004 as filed with the Securities and Exchange Commission on the date
hereof (the Report), I, Jay N. Torok, Principal Executive Officer of the Company, certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:  (1)
    The Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and(2)
    The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. /s/ Jay N. TorokJay N. TorokChairman of the Board and
Principal Executive OfficerJanuary 18, 2005 This certification is made solely for purpose of 18 U.S.C. Section 1350, subject to the knowledge
standard contained therein, and not for any other purpose. This certification is not being filed
as part of this Report or as a separate disclosure document.
#### STATE OF CONNECTICUT *v.*MOHAMMED ALI

(AC 18424)

Lavery, C. J., and Landau and Hennessy, Js.

Argued May 31

officially released August 1, 2000

*Joseph S.*Elder, for the appellant (defendant).

*James M. Ralls,*assistant state’s attorney, with whom, on the brief, were *James E. Thomas,*state’s attorney, and *Vicki Melchiorre,*senior assistant state’s attorney, for the appellee (state).

*Opinion*

PER CURIAM.

The defendant, Mohammed Ali, appeals from the judgment of conviction, rendered after *186a jury trial, of sexual assault in the first degree in violation of General Statutes § 53a-70 (a) (1), sexual assault in the second degree in violation of General Statutes § 53a-71 (a) (2) and unlawful restraint in the second degree in violation of General Statutes § 53a-96. On appeal, the defendant has, essentially, attacked the factual findings of the trial court.

After a careful review of the record, we conclude that the court did not abuse its discretion when it found that the victim’s capacity or competency to testify was “minimally credible” and denied the defendant’s post-trial motion for psychological testing of the victim. See *State*v. *Weinberg,*215 Conn. 231, 241-45, 575 A.2d 1003, cert. denied, 498 U.S. 967, 111 S. Ct. 430, 112 L. Ed. 2d 413 (1990); *State*v. *James,*211 Conn. 555, 563-65, 560 A.2d 426 (1989). Additionally, the court’s conclusion that the victim was competent to testify is supported by the evidence, and the court’s related underlying factual findings are not clearly erroneous. See *State*v. *Hydock,*51 Conn. App. 753, 764, 725 A.2d 379, cert. denied, 248 Conn. 921, 733 A.2d 846 (1999). We therefore conclude that the court did not abuse its discretion and that its decision conforms to the applicable law.

The judgment is affirmed.
IV 

114TH CONGRESS 

1ST SESSION H. RES. 415 

Expressing the sense of the House of Representatives that regular order 

should be restored in the House and Senate. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 10, 2015 

Mr. NOLAN submitted the following resolution; which was referred to the 

Committee on Rules 

RESOLUTION 

Expressing the sense of the House of Representatives that 

regular order should be restored in the House and Senate. 

1 Resolved, 

2 SECTION 1. REQUIRING REGULAR ORDER IN THE HOUSE 

3 AND SENATE. 

4 It is the sense of the House of Representatives that— 

5 (1) it should not be in order to consider a bill 

6 or resolution in the House unless each committee to 

7 which the bill or resolution is referred— 

8 (A) had a hearing on the bill or resolution 

9 at which amendments were permitted to be ofVerDate Sep 11 2014 02:54 Sep 11, 2015 Jkt 049200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\HR415.IH HR415

emcdonald on DSK67QTVN1PROD with BILLS
2 

•HRES 415 IH 

1 fered and debated and a vote was taken on each 

2 amendment offered and on final passage, and 

3 (B) filed a report with respect to the bill 

4 or resolution; 

5 (2) a conference report should not be filed in 

6 the House unless— 

7 (A) the conference committee held at least 

8 3 meetings in which all members of the con9 ference committee were allowed to be present, 

10 (B) all items of difference between the 

11 House and Senate were addressed, voted on, 

12 and resolved by the full conference committee 

13 membership, and 

14 (C) printed or electronic copies of the con15 ference report and the accompanying joint ex16 planatory statement were available to Members 

17 and Delegates for at least 48 hours prior to fil18 ing; 

19 (3) the House and Senate should schedule si20 multaneous 5-day work weeks in Washington and 

21 district work periods; and 

22 (4) every bill brought to committee should be 

23 open to amendment and every bill brought to the 


emcdonald on DSK67QTVN1PROD with BILLS
3 

•HRES 415 IH 

1 floor of the House for a vote should be considered 

2 under an open rule. 

Æ 


emcdonald on DSK67QTVN1PROD with BILLS